MedPath

RINGZA

RINGZA

Approved
DIN Number

02554070

Drug Class

Human

Market Date

N/A

Company
HC

Duchesnay Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554070
AIG Number0266384001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN
Product Specifications
Dosage FormRing (Slow-Release)
Route of AdministrationVaginal
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

ETHINYL ESTRADIOLActive
Strength: 17.4 MG
Monograph: ETHINYL ESTRADIOL
SEGESTERONE ACETATEActive
Strength: 103 MG
Monograph: SEGESTERONE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.